We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

138 hedge funds and large institutions have $227M invested in Viking Therapeutics in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 52 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more call options, than puts

Call options by funds: $7.14M | Put options by funds: $1.7M

4% less funds holding

Funds holding: 144 → 138 (-6)

7.54% less ownership

Funds ownership: 56.03% → 48.49% (-7.5%)

13% less capital invested

Capital invested by funds: $260M → $227M (-$33.3M)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

25% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 52

Holders
138
Holders Change
-6
Holders Change %
-4.17%
% of All Funds
2.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
39
Reduced
52
Closed
20
Calls
$7.14M
Puts
$1.7M
Net Calls
+$5.44M
Net Calls Change
-$935K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$1.94M
2
Goldman Sachs
Goldman Sachs
New York
+$1.44M
3
Citadel Advisors
Citadel Advisors
Florida
+$663K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$568K
5
PP
PDT Partners
New York
+$564K

Top Sellers

1
State Street
State Street
Massachusetts
-$10.7M
2
BBA
Baker Bros. Advisors
New York
-$2.3M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.75M
4
Aviva
Aviva
United Kingdom
-$1.31M
5
IC
Ikarian Capital
Texas
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
GWM
126
Geneos Wealth Management
Colorado
$2K -$11.3K -1,910 -81%
TWA
127
TCI Wealth Advisors
Arizona
$2K -$594 -100 -25%
CFGS
128
Concourse Financial Group Securities
Alabama
$1K – – –
FIA
129
FNY Investment Advisers
New York
$1K – – –
SSB
130
Sandy Spring Bank
Maryland
$1K – – –
S
131
SignatureFD
Georgia
$1K – – –
EVM
132
Eaton Vance Management
Massachusetts
$1K +$873 +147 New
Fidelity Investments
133
Fidelity Investments
Massachusetts
$1K +$1.11K +187 +2,338%
AIG
134
American International Group
New York
$230 +$689 +116 +0.3%
BBA
135
Baker Bros. Advisors
New York
– -$2.3M -363,980 Closed
Aviva
136
Aviva
United Kingdom
– -$1.31M -207,322 Closed
California Public Employees Retirement System
137
California Public Employees Retirement System
California
– -$843K -133,300 Closed
Jane Street
138
Jane Street
New York
– -$439K -73,941 Closed
SFI
139
Susquehanna Fundamental Investments
Pennsylvania
– -$460K -72,700 Closed
FAIM
140
Financial Advocates Investment Management
Washington
– -$837K -16,500 Closed
WS
141
Wedbush Securities
California
– -$104K -16,500 Closed
BCM
142
Bayesian Capital Management
New York
– -$81K -12,800 Closed
HS
143
HighVista Strategies
Massachusetts
– -$64K -10,100 Closed
Pacer Advisors
144
Pacer Advisors
Pennsylvania
– -$51K -8,140 Closed
Bank Julius Baer & Co
145
Bank Julius Baer & Co
Switzerland
– -$40K -6,400 Closed
SPIA
146
Steward Partners Investment Advisory
New York
– -$39.2K -6,200 Closed
SWP
147
ShoreHaven Wealth Partners
New Jersey
– -$9K -1,495 Closed
SFS
148
Sowell Financial Services
Arkansas
– -$8K -1,393 Closed
RFA
149
Reilly Financial Advisors
California
– -$8K -1,250 Closed
VFA
150
Valeo Financial Advisors
Indiana
– -$4K -710 Closed
3 4 5
6
7

VKTX Hedge Fund Activity: Q2 2021 in Review

138 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q2 2021, worth a combined $227M — down 13% from $260M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of VKTX and 15 opened new positions — a net loss of 5 holders — while 52 trimmed existing stakes and 39 added.

The largest buyer was Morgan Stanley, adding an estimated $1.94M. The largest seller was State Street, cutting an estimated $10.7M.

  • 138 institutional investors held Viking Therapeutics (VKTX) as of Q2 2021, down from 144 in Q1 2021.
  • Funds reported $227M of Viking Therapeutics stock for Q2 2021, down 13% quarter-over-quarter.
  • 15 funds opened new Viking Therapeutics positions in Q2 2021 and 20 closed out, a net change of -5 holders.
  • The largest Viking Therapeutics buyer in Q2 2021 was Morgan Stanley, an estimated $1.94M added.
  • The largest Viking Therapeutics seller in Q2 2021 was State Street, an estimated $10.7M sold.

Based on aggregated 13F filings for Q2 2021.